This was the ADR's fourth consecutive day of gains.

AstraZeneca PLC closed 21.95% short of its 52-week high of £133.88, which the company reached on September 3rd.

AstraZeneca PLC (NASDAQ:AZN) is one of the 10 best defensive stocks to buy in a volatile market. On July 4, the company ...

AstraZeneca’s rare disease unit Alexion has penned a $825 million deal for adeno-associated virus (AAV) capsids from existing ...

Despite a Q1 revenue miss due to currency headwinds, core EPS beat expectations for AstraZeneca. Read why AZN stock is a Buy.

The deal gives AstraZeneca’s rare disease unit Alexion access to specialized capsids developed by the Japanese biotech JCR ...

Anal cancer is a rare yet increasing cancer linked primarily to high-risk HPV strains such as HPV-16 and HPV-18. Key risk factors include weakened immune systems, age over 50, and high-risk sexual ...

Review the current AstraZeneca PLC ADR (AZN:XNAS) dividend yield and history to decide if AZN is the best investment for you.

Read about AstraZeneca PLC ADR (AZN:XNAS) stock and today's latest news and financial updates.

The anti-GPC3 targeted therapies market is expected to witness growth in the coming years, driven by the increasing incidence of cancer cases, clinical pipeline activity, and anticipated regulatory ...

Challenging the minister earlier over AstraZeneca and its reported exit from the London market, Tory shadow Treasury minister ...